Hyperoside alleviates postmenopausal osteoporosis via regulating miR-19a-5p/IL-17A axis.

Hongqiang An,Chu Chu,Zhen Zhang,Yunhong Zhang,Ran Wei,Bin Wang,Ke Xu,Lihua Li,Yonglin Liu,Gang Li,Xia Li

American journal of reproductive immunology (New York, N.Y. : 1989)（2023）

引用 0|浏览2

暂无评分

摘要

Overall, these data demonstrated that miR-19a-5p/IL-17A axis might serve as novel therapeutic candidate for PMO. Hyp could relieve bone resorption by targeting the miR-19a-5p/IL-17A axis in OVX mice and exhibited prospective for the treatment of PMO.

查看译文

关键词

Hyperoside, IL-17A, miRNA-19a-5p, postmenopausal osteoporosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要